2019-11-29 · Notice · 2019-25850
Determination of Regulatory Review Period for Purposes of Patent Extension; OZEMPIC
Semaglutide
Open attributed record →Federal Register publication year
2019 FDA Federal Register peptide records
3 documents attributed to FDA and HHS and published in 2019, connected only through exact reviewed peptide-name matches.
2019-09-17 · Notice · 2019-20108
Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability
Plecanatide
Open attributed record →2019-05-30 · Notice · 2019-11243
Determination That LUPRON (Leuprolide Acetate) Injection, 1 Milligram/0.2 Milliliter, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness
Leuprolide
Open attributed record →